国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

INTEGRATION OF PROJECT-PRODUCT LIFECYCLE IN PHARMACEUTICAL INDUSTRY

Divya Chauhan, Nusrat Khan

One meaningful and holistic approach to today’s current challenges within the pharmaceutical industry is to focus on Product Lifecycle Management (PLM). PLM has provided many pharmaceutical organizations with the ability to get products to market quicker, ensure greater regulatory compliance and efficiencies while reducing development costs. A product life cycle is a conceptual map of - where a product's sales are and where they may be headed. However, it has no comment on what to do with the product. If a company believes its product is entering the decline phase, it will probably create a plan to either rejuvenate the product or cease production, but that is not inherent in the product life cycle. Thus, comes the concept of project life cycle (PLC), which is all about action. A project life cycle maps out the steps needed to complete a project with specific targeted results. Although these two lifecycles are talked about separately but if integrated can be of greater use to an organization

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。